Cargando…
Vitamin B12 effectiveness in the management of hospitalized COVID‐19 and its clinical outcomes and complications: A randomized clinical trial
BACKGROUND AND AIMS: Since 2019, severe acute respiratory syndrome coronavirus 2, has spread and challenged the health care system for treatment which is mainly limited to supportive care. It is well‐established that malnutrition impedes the immunity in human bodies, and makes it vulnerable to micro...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500256/ https://www.ncbi.nlm.nih.gov/pubmed/37720165 http://dx.doi.org/10.1002/hsr2.1509 |
_version_ | 1785105884689465344 |
---|---|
author | Erfani, Zahra Alizadeh, Nafiseh Faraji, Neda Teymouri, Alireza |
author_facet | Erfani, Zahra Alizadeh, Nafiseh Faraji, Neda Teymouri, Alireza |
author_sort | Erfani, Zahra |
collection | PubMed |
description | BACKGROUND AND AIMS: Since 2019, severe acute respiratory syndrome coronavirus 2, has spread and challenged the health care system for treatment which is mainly limited to supportive care. It is well‐established that malnutrition impedes the immunity in human bodies, and makes it vulnerable to microorganisms. Vitamin B12 is one of the agents that has critical roles in body systems. Thus, the following clinical trial was conducted to assess its possible therapeutic value in COVID‐19 patients. METHOD: The present randomized clinical trial was carried out in Baharlou Hospital, and patients with confirmed COVID‐19 infection within 24 h of admission were included. We used quadruple blocks randomization to divide patients into groups of case and control. The case group received 1000 mg of vitamin B12, daily for 7 day while the patients in control group were administered distilled water as placebo. The studied outcomes were duration of hospitalization, need for intensive care unit (ICU), mechanical ventilation, mortality rate and laboratory findings. The statistical analysis was done via SPSS version 22. RESULTS: After implementing inclusion and exclusion criteria, 34 participants were included in the study, 20 of which were male. Serum levels of creatinine, LDH (Lactate dehydrogenase), Ferritin, and CRP (C‐reactive protein) had decreased in both groups. The improving changes of CRP, LDH, ferritin and creatinine was higher in case group. The increase of Alanine Transaminase and D‐dimer was higher in control group. however there was no statistically significant difference. More patients were admitted to ICU in the control group but the difference was not statistically significant. Duration of hospitalization did not differ statistically between the groups. No in hospital mortality has been recorded. CONCLUSION: Our study suggests that vitamin B12 supplementation seem to have curative effect in COVID‐19. Nutritious diet is necessary for proper functioning of the immune system. Since malnutrition is associated with poor prognosis in COVID‐19 patients, and limited number of participants in this study, we suggest performing meta‐analysis on similar studies to reach reliable result. |
format | Online Article Text |
id | pubmed-10500256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105002562023-09-15 Vitamin B12 effectiveness in the management of hospitalized COVID‐19 and its clinical outcomes and complications: A randomized clinical trial Erfani, Zahra Alizadeh, Nafiseh Faraji, Neda Teymouri, Alireza Health Sci Rep Original Research BACKGROUND AND AIMS: Since 2019, severe acute respiratory syndrome coronavirus 2, has spread and challenged the health care system for treatment which is mainly limited to supportive care. It is well‐established that malnutrition impedes the immunity in human bodies, and makes it vulnerable to microorganisms. Vitamin B12 is one of the agents that has critical roles in body systems. Thus, the following clinical trial was conducted to assess its possible therapeutic value in COVID‐19 patients. METHOD: The present randomized clinical trial was carried out in Baharlou Hospital, and patients with confirmed COVID‐19 infection within 24 h of admission were included. We used quadruple blocks randomization to divide patients into groups of case and control. The case group received 1000 mg of vitamin B12, daily for 7 day while the patients in control group were administered distilled water as placebo. The studied outcomes were duration of hospitalization, need for intensive care unit (ICU), mechanical ventilation, mortality rate and laboratory findings. The statistical analysis was done via SPSS version 22. RESULTS: After implementing inclusion and exclusion criteria, 34 participants were included in the study, 20 of which were male. Serum levels of creatinine, LDH (Lactate dehydrogenase), Ferritin, and CRP (C‐reactive protein) had decreased in both groups. The improving changes of CRP, LDH, ferritin and creatinine was higher in case group. The increase of Alanine Transaminase and D‐dimer was higher in control group. however there was no statistically significant difference. More patients were admitted to ICU in the control group but the difference was not statistically significant. Duration of hospitalization did not differ statistically between the groups. No in hospital mortality has been recorded. CONCLUSION: Our study suggests that vitamin B12 supplementation seem to have curative effect in COVID‐19. Nutritious diet is necessary for proper functioning of the immune system. Since malnutrition is associated with poor prognosis in COVID‐19 patients, and limited number of participants in this study, we suggest performing meta‐analysis on similar studies to reach reliable result. John Wiley and Sons Inc. 2023-09-14 /pmc/articles/PMC10500256/ /pubmed/37720165 http://dx.doi.org/10.1002/hsr2.1509 Text en © 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Erfani, Zahra Alizadeh, Nafiseh Faraji, Neda Teymouri, Alireza Vitamin B12 effectiveness in the management of hospitalized COVID‐19 and its clinical outcomes and complications: A randomized clinical trial |
title | Vitamin B12 effectiveness in the management of hospitalized COVID‐19 and its clinical outcomes and complications: A randomized clinical trial |
title_full | Vitamin B12 effectiveness in the management of hospitalized COVID‐19 and its clinical outcomes and complications: A randomized clinical trial |
title_fullStr | Vitamin B12 effectiveness in the management of hospitalized COVID‐19 and its clinical outcomes and complications: A randomized clinical trial |
title_full_unstemmed | Vitamin B12 effectiveness in the management of hospitalized COVID‐19 and its clinical outcomes and complications: A randomized clinical trial |
title_short | Vitamin B12 effectiveness in the management of hospitalized COVID‐19 and its clinical outcomes and complications: A randomized clinical trial |
title_sort | vitamin b12 effectiveness in the management of hospitalized covid‐19 and its clinical outcomes and complications: a randomized clinical trial |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500256/ https://www.ncbi.nlm.nih.gov/pubmed/37720165 http://dx.doi.org/10.1002/hsr2.1509 |
work_keys_str_mv | AT erfanizahra vitaminb12effectivenessinthemanagementofhospitalizedcovid19anditsclinicaloutcomesandcomplicationsarandomizedclinicaltrial AT alizadehnafiseh vitaminb12effectivenessinthemanagementofhospitalizedcovid19anditsclinicaloutcomesandcomplicationsarandomizedclinicaltrial AT farajineda vitaminb12effectivenessinthemanagementofhospitalizedcovid19anditsclinicaloutcomesandcomplicationsarandomizedclinicaltrial AT teymourialireza vitaminb12effectivenessinthemanagementofhospitalizedcovid19anditsclinicaloutcomesandcomplicationsarandomizedclinicaltrial |